At the recent ARVO meeting, Wei Zhang presented the latest findings from the University of Cologne on a new treatment to regress corneal neovascularization in mice
Month: May 2024
Genetic research shows promise for developing a treatment for the rare eye disease Aniridia – Study by UKK
At the recent ARVO meeting, Karina Hadriaan presented the latest findings from the University of Cologne on a new treatment to regress corneal neovascularization in mice
Effectiveness of a new eyedrop in healing wounds on the cornea in rats – Study by INSERM
At the recent ARVO meeting, Daniela Braz presented the latest findings from INSERM on the development of a new eye drop to treat cornea wounds in mice.
Exploring the use of spironolactone to treat diseases of the cornea – Study by INSERM
At the recent ARVO meeting, Raquel Gregorio presented the latest findings from INSERM on the use of spironolactone for treating corneal diseases.
A novel combination treatment offers promise for corneal vessel regression and longer graft survival – Study by UKK
At the recent ARVO meeting, Meert Mestanoglu presented UKK’s ongoing research on a novel combination treatment for corneal vessel regression.
Restore Vision partner KOL hosts Olisens symposium at SFO Congress
Restore Vision partner’s KOL host symposium on SFO 2024 and explored the use of Olisens on the treatment of Corneal Neovessels
Restore Vision at ARVO Conference in Seattle
The Restore Vision Consortium had a significant presence at the ARVO 2024 “Vision for the Future” conference from 05th-09th May 2024 in Seattle, Washington to present our work on new therapies for rare ocular diseases.